nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—VEGFA—chronic obstructive pulmonary disease	0.161	0.398	CbGaD
Carvedilol—ADRB2—chronic obstructive pulmonary disease	0.0904	0.224	CbGaD
Carvedilol—CYP1A1—chronic obstructive pulmonary disease	0.0775	0.192	CbGaD
Carvedilol—CYP1A2—chronic obstructive pulmonary disease	0.0747	0.185	CbGaD
Carvedilol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0463	0.128	CbGbCtD
Carvedilol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0456	0.127	CbGbCtD
Carvedilol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0351	0.0974	CbGbCtD
Carvedilol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0351	0.0974	CbGbCtD
Carvedilol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0346	0.0959	CbGbCtD
Carvedilol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0346	0.0959	CbGbCtD
Carvedilol—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0181	0.0503	CbGbCtD
Carvedilol—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0157	0.0436	CbGbCtD
Carvedilol—NPPB—pulmonary artery—chronic obstructive pulmonary disease	0.0125	0.241	CbGeAlD
Carvedilol—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.00963	0.0267	CbGbCtD
Carvedilol—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.00963	0.0267	CbGbCtD
Carvedilol—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00909	0.0252	CbGbCtD
Carvedilol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00881	0.0244	CbGbCtD
Carvedilol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00881	0.0244	CbGbCtD
Carvedilol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00785	0.0218	CbGbCtD
Carvedilol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00739	0.0205	CbGbCtD
Carvedilol—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0073	0.0202	CbGbCtD
Carvedilol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00499	0.0138	CbGbCtD
Carvedilol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00476	0.0132	CbGbCtD
Carvedilol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00424	0.0118	CbGbCtD
Carvedilol—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00416	0.0115	CbGbCtD
Carvedilol—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00393	0.0109	CbGbCtD
Carvedilol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00249	0.00691	CbGbCtD
Carvedilol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00235	0.00652	CbGbCtD
Carvedilol—NPPB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00169	0.0327	CbGeAlD
Carvedilol—SELE—respiratory system—chronic obstructive pulmonary disease	0.00142	0.0274	CbGeAlD
Carvedilol—VCAM1—respiratory system—chronic obstructive pulmonary disease	0.00131	0.0252	CbGeAlD
Carvedilol—HIF1A—respiratory system—chronic obstructive pulmonary disease	0.00126	0.0243	CbGeAlD
Carvedilol—SELE—connective tissue—chronic obstructive pulmonary disease	0.00125	0.0241	CbGeAlD
Carvedilol—GJA1—respiratory system—chronic obstructive pulmonary disease	0.00122	0.0235	CbGeAlD
Carvedilol—SELE—bronchus—chronic obstructive pulmonary disease	0.00117	0.0226	CbGeAlD
Carvedilol—VCAM1—connective tissue—chronic obstructive pulmonary disease	0.00115	0.0222	CbGeAlD
Carvedilol—SELE—smooth muscle tissue—chronic obstructive pulmonary disease	0.00114	0.0221	CbGeAlD
Carvedilol—HIF1A—connective tissue—chronic obstructive pulmonary disease	0.00111	0.0214	CbGeAlD
Carvedilol—VCAM1—bronchus—chronic obstructive pulmonary disease	0.00108	0.0207	CbGeAlD
Carvedilol—GJA1—connective tissue—chronic obstructive pulmonary disease	0.00107	0.0207	CbGeAlD
Carvedilol—NDUFC2—respiratory system—chronic obstructive pulmonary disease	0.00106	0.0205	CbGeAlD
Carvedilol—VCAM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00105	0.0203	CbGeAlD
Carvedilol—SELE—trachea—chronic obstructive pulmonary disease	0.00105	0.0203	CbGeAlD
Carvedilol—HIF1A—bronchus—chronic obstructive pulmonary disease	0.00103	0.02	CbGeAlD
Carvedilol—HIF1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00101	0.0195	CbGeAlD
Carvedilol—GJA1—bronchus—chronic obstructive pulmonary disease	0.001	0.0194	CbGeAlD
Carvedilol—ADRB3—connective tissue—chronic obstructive pulmonary disease	0.000984	0.019	CbGeAlD
Carvedilol—GJA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000982	0.0189	CbGeAlD
Carvedilol—VCAM1—trachea—chronic obstructive pulmonary disease	0.000966	0.0186	CbGeAlD
Carvedilol—HIF1A—trachea—chronic obstructive pulmonary disease	0.000929	0.0179	CbGeAlD
Carvedilol—GJA1—trachea—chronic obstructive pulmonary disease	0.000901	0.0174	CbGeAlD
Carvedilol—NDUFC2—bronchus—chronic obstructive pulmonary disease	0.000874	0.0169	CbGeAlD
Carvedilol—VEGFA—bronchus—chronic obstructive pulmonary disease	0.000792	0.0153	CbGeAlD
Carvedilol—NDUFC2—trachea—chronic obstructive pulmonary disease	0.000784	0.0151	CbGeAlD
Carvedilol—VEGFA—smooth muscle tissue—chronic obstructive pulmonary disease	0.000775	0.015	CbGeAlD
Carvedilol—SELE—lung—chronic obstructive pulmonary disease	0.000754	0.0146	CbGeAlD
Carvedilol—VEGFA—trachea—chronic obstructive pulmonary disease	0.000712	0.0137	CbGeAlD
Carvedilol—VCAM1—lung—chronic obstructive pulmonary disease	0.000694	0.0134	CbGeAlD
Carvedilol—HIF1A—lung—chronic obstructive pulmonary disease	0.000667	0.0129	CbGeAlD
Carvedilol—GJA1—lung—chronic obstructive pulmonary disease	0.000647	0.0125	CbGeAlD
Carvedilol—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.000567	0.305	CrCbGaD
Carvedilol—NDUFC2—lung—chronic obstructive pulmonary disease	0.000564	0.0109	CbGeAlD
Carvedilol—Bopindolol—ADRB2—chronic obstructive pulmonary disease	0.000525	0.282	CrCbGaD
Carvedilol—VEGFA—lung—chronic obstructive pulmonary disease	0.000511	0.00987	CbGeAlD
Carvedilol—GJA1—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.00043	0.203	CbGdCrCtD
Carvedilol—GJA1—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.00042	0.199	CbGdCrCtD
Carvedilol—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000402	0.00776	CbGeAlD
Carvedilol—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000376	0.00726	CbGeAlD
Carvedilol—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000299	0.00576	CbGeAlD
Carvedilol—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000295	0.00569	CbGeAlD
Carvedilol—GJA1—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.000289	0.137	CbGdCrCtD
Carvedilol—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000283	0.00547	CbGeAlD
Carvedilol—GJA1—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.134	CbGdCrCtD
Carvedilol—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000269	0.00519	CbGeAlD
Carvedilol—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000259	0.005	CbGeAlD
Carvedilol—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000254	0.00491	CbGeAlD
Carvedilol—ADRB1—lung—chronic obstructive pulmonary disease	0.000243	0.00468	CbGeAlD
Carvedilol—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000243	0.00468	CbGeAlD
Carvedilol—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000242	0.00467	CbGeAlD
Carvedilol—Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.000238	0.128	CrCbGaD
Carvedilol—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000228	0.0044	CbGeAlD
Carvedilol—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000226	0.00436	CbGeAlD
Carvedilol—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000218	0.0042	CbGeAlD
Carvedilol—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000208	0.00402	CbGeAlD
Carvedilol—GJA1—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.0972	CbGdCrCtD
Carvedilol—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000203	0.00392	CbGeAlD
Carvedilol—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000197	0.106	CrCbGaD
Carvedilol—PTGS1—trachea—chronic obstructive pulmonary disease	0.000191	0.00369	CbGeAlD
Carvedilol—ADRA2C—lung—chronic obstructive pulmonary disease	0.000183	0.00353	CbGeAlD
Carvedilol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.0909	CrCbGaD
Carvedilol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000163	0.0876	CrCbGaD
Carvedilol—CYP1A2—lung—chronic obstructive pulmonary disease	0.000159	0.00306	CbGeAlD
Carvedilol—CYP1A1—lung—chronic obstructive pulmonary disease	0.000156	0.00302	CbGeAlD
Carvedilol—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000153	0.00295	CbGeAlD
Carvedilol—ADRA2A—lung—chronic obstructive pulmonary disease	0.000146	0.00281	CbGeAlD
Carvedilol—CYP2E1—lung—chronic obstructive pulmonary disease	0.000143	0.00275	CbGeAlD
Carvedilol—PTGS1—lung—chronic obstructive pulmonary disease	0.000137	0.00265	CbGeAlD
Carvedilol—ABCB1—trachea—chronic obstructive pulmonary disease	0.000113	0.00218	CbGeAlD
Carvedilol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00106	CcSEcCtD
Carvedilol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00105	CcSEcCtD
Carvedilol—Infection—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00105	CcSEcCtD
Carvedilol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00104	CcSEcCtD
Carvedilol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00104	CcSEcCtD
Carvedilol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00104	CcSEcCtD
Carvedilol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000106	0.00104	CcSEcCtD
Carvedilol—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00104	CcSEcCtD
Carvedilol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Carvedilol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Carvedilol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Carvedilol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Carvedilol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Carvedilol—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Carvedilol—Infection—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Carvedilol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000104	0.00103	CcSEcCtD
Carvedilol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.00103	CcSEcCtD
Carvedilol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000104	0.00102	CcSEcCtD
Carvedilol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00102	CcSEcCtD
Carvedilol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000103	0.00101	CcSEcCtD
Carvedilol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00101	CcSEcCtD
Carvedilol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000998	CcSEcCtD
Carvedilol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000998	CcSEcCtD
Carvedilol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000991	CcSEcCtD
Carvedilol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000987	CcSEcCtD
Carvedilol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000987	CcSEcCtD
Carvedilol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	9.98e-05	0.000982	CcSEcCtD
Carvedilol—Shock—Salbutamol—chronic obstructive pulmonary disease	9.98e-05	0.000982	CcSEcCtD
Carvedilol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	9.96e-05	0.00098	CcSEcCtD
Carvedilol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	9.9e-05	0.000974	CcSEcCtD
Carvedilol—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000973	CcSEcCtD
Carvedilol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	9.85e-05	0.000969	CcSEcCtD
Carvedilol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	9.81e-05	0.000965	CcSEcCtD
Carvedilol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	9.8e-05	0.000965	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	9.79e-05	0.000963	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	9.79e-05	0.000963	CcSEcCtD
Carvedilol—Insomnia—Formoterol—chronic obstructive pulmonary disease	9.71e-05	0.000956	CcSEcCtD
Carvedilol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	9.71e-05	0.000956	CcSEcCtD
Carvedilol—Anorexia—Salbutamol—chronic obstructive pulmonary disease	9.67e-05	0.000951	CcSEcCtD
Carvedilol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	9.66e-05	0.00095	CcSEcCtD
Carvedilol—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000946	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	9.58e-05	0.000943	CcSEcCtD
Carvedilol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	9.58e-05	0.000942	CcSEcCtD
Carvedilol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	9.58e-05	0.000942	CcSEcCtD
Carvedilol—Somnolence—Formoterol—chronic obstructive pulmonary disease	9.55e-05	0.000939	CcSEcCtD
Carvedilol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	9.55e-05	0.000939	CcSEcCtD
Carvedilol—Insomnia—Montelukast—chronic obstructive pulmonary disease	9.51e-05	0.000936	CcSEcCtD
Carvedilol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	9.48e-05	0.000932	CcSEcCtD
Carvedilol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	9.45e-05	0.00093	CcSEcCtD
Carvedilol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	9.45e-05	0.00093	CcSEcCtD
Carvedilol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	9.45e-05	0.000929	CcSEcCtD
Carvedilol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	9.42e-05	0.000926	CcSEcCtD
Carvedilol—Injury—Prednisone—chronic obstructive pulmonary disease	9.36e-05	0.00092	CcSEcCtD
Carvedilol—Somnolence—Montelukast—chronic obstructive pulmonary disease	9.35e-05	0.00092	CcSEcCtD
Carvedilol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	9.33e-05	0.000918	CcSEcCtD
Carvedilol—Weight increased—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.000916	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	9.27e-05	0.000912	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	9.27e-05	0.000912	CcSEcCtD
Carvedilol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	9.26e-05	0.000911	CcSEcCtD
Carvedilol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	9.26e-05	0.000911	CcSEcCtD
Carvedilol—Fatigue—Formoterol—chronic obstructive pulmonary disease	9.26e-05	0.000911	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	9.24e-05	0.000909	CcSEcCtD
Carvedilol—Pain—Arformoterol—chronic obstructive pulmonary disease	9.18e-05	0.000904	CcSEcCtD
Carvedilol—Pain—Formoterol—chronic obstructive pulmonary disease	9.18e-05	0.000904	CcSEcCtD
Carvedilol—Constipation—Formoterol—chronic obstructive pulmonary disease	9.18e-05	0.000904	CcSEcCtD
Carvedilol—Constipation—Arformoterol—chronic obstructive pulmonary disease	9.18e-05	0.000904	CcSEcCtD
Carvedilol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	9.17e-05	0.000902	CcSEcCtD
Carvedilol—Amnesia—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.0009	CcSEcCtD
Carvedilol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	9.11e-05	0.000896	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	9.08e-05	0.000894	CcSEcCtD
Carvedilol—Fatigue—Montelukast—chronic obstructive pulmonary disease	9.07e-05	0.000892	CcSEcCtD
Carvedilol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	9.04e-05	0.000889	CcSEcCtD
Carvedilol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	9.02e-05	0.000887	CcSEcCtD
Carvedilol—Pain—Montelukast—chronic obstructive pulmonary disease	9e-05	0.000885	CcSEcCtD
Carvedilol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	8.99e-05	0.000884	CcSEcCtD
Carvedilol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	8.97e-05	0.000883	CcSEcCtD
Carvedilol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	8.94e-05	0.000879	CcSEcCtD
Carvedilol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	8.93e-05	0.000878	CcSEcCtD
Carvedilol—Purpura—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000878	CcSEcCtD
Carvedilol—Rash—Aminophylline—chronic obstructive pulmonary disease	8.9e-05	0.000875	CcSEcCtD
Carvedilol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	8.89e-05	0.000875	CcSEcCtD
Carvedilol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	8.85e-05	0.000871	CcSEcCtD
Carvedilol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	8.85e-05	0.000871	CcSEcCtD
Carvedilol—Headache—Aminophylline—chronic obstructive pulmonary disease	8.84e-05	0.00087	CcSEcCtD
Carvedilol—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	8.82e-05	0.000867	CcSEcCtD
Carvedilol—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000867	CcSEcCtD
Carvedilol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	8.8e-05	0.000866	CcSEcCtD
Carvedilol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	8.78e-05	0.000864	CcSEcCtD
Carvedilol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	8.78e-05	0.000864	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.76e-05	0.000861	CcSEcCtD
Carvedilol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	8.74e-05	0.00086	CcSEcCtD
Carvedilol—Pain—Salbutamol—chronic obstructive pulmonary disease	8.67e-05	0.000853	CcSEcCtD
Carvedilol—Constipation—Salbutamol—chronic obstructive pulmonary disease	8.67e-05	0.000853	CcSEcCtD
Carvedilol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	8.6e-05	0.000846	CcSEcCtD
Carvedilol—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000846	CcSEcCtD
Carvedilol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	8.53e-05	0.000839	CcSEcCtD
Carvedilol—Urticaria—Formoterol—chronic obstructive pulmonary disease	8.53e-05	0.000839	CcSEcCtD
Carvedilol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	8.49e-05	0.000835	CcSEcCtD
Carvedilol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	8.49e-05	0.000835	CcSEcCtD
Carvedilol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	8.49e-05	0.000835	CcSEcCtD
Carvedilol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	8.49e-05	0.000835	CcSEcCtD
Carvedilol—Affect lability—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000833	CcSEcCtD
Carvedilol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	8.46e-05	0.000832	CcSEcCtD
Carvedilol—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000826	CcSEcCtD
Carvedilol—Rash—Tiotropium—chronic obstructive pulmonary disease	8.39e-05	0.000826	CcSEcCtD
Carvedilol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	8.38e-05	0.000825	CcSEcCtD
Carvedilol—Nausea—Aminophylline—chronic obstructive pulmonary disease	8.38e-05	0.000825	CcSEcCtD
Carvedilol—Urticaria—Montelukast—chronic obstructive pulmonary disease	8.36e-05	0.000822	CcSEcCtD
Carvedilol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	8.36e-05	0.000822	CcSEcCtD
Carvedilol—Headache—Tiotropium—chronic obstructive pulmonary disease	8.34e-05	0.00082	CcSEcCtD
Carvedilol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	8.33e-05	0.00082	CcSEcCtD
Carvedilol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	8.32e-05	0.000818	CcSEcCtD
Carvedilol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	8.32e-05	0.000818	CcSEcCtD
Carvedilol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	8.29e-05	0.000816	CcSEcCtD
Carvedilol—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	8.23e-05	0.00081	CcSEcCtD
Carvedilol—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	8.19e-05	0.000805	CcSEcCtD
Carvedilol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000804	CcSEcCtD
Carvedilol—Mood swings—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000801	CcSEcCtD
Carvedilol—ABCB1—lung—chronic obstructive pulmonary disease	8.13e-05	0.00157	CbGeAlD
Carvedilol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.06e-05	0.000793	CcSEcCtD
Carvedilol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.02e-05	0.000789	CcSEcCtD
Carvedilol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.02e-05	0.000789	CcSEcCtD
Carvedilol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	7.91e-05	0.000778	CcSEcCtD
Carvedilol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	7.91e-05	0.000778	CcSEcCtD
Carvedilol—Nausea—Tiotropium—chronic obstructive pulmonary disease	7.9e-05	0.000778	CcSEcCtD
Carvedilol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	7.89e-05	0.000776	CcSEcCtD
Carvedilol—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	7.83e-05	0.00077	CcSEcCtD
Carvedilol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	7.75e-05	0.000763	CcSEcCtD
Carvedilol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	7.71e-05	0.000758	CcSEcCtD
Carvedilol—Asthenia—Formoterol—chronic obstructive pulmonary disease	7.71e-05	0.000758	CcSEcCtD
Carvedilol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	7.6e-05	0.000748	CcSEcCtD
Carvedilol—Pruritus—Formoterol—chronic obstructive pulmonary disease	7.6e-05	0.000748	CcSEcCtD
Carvedilol—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000746	CcSEcCtD
Carvedilol—Asthenia—Montelukast—chronic obstructive pulmonary disease	7.55e-05	0.000743	CcSEcCtD
Carvedilol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	7.47e-05	0.000735	CcSEcCtD
Carvedilol—Pruritus—Montelukast—chronic obstructive pulmonary disease	7.44e-05	0.000732	CcSEcCtD
Carvedilol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	7.35e-05	0.000723	CcSEcCtD
Carvedilol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	7.35e-05	0.000723	CcSEcCtD
Carvedilol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.28e-05	0.000716	CcSEcCtD
Carvedilol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000712	CcSEcCtD
Carvedilol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	7.2e-05	0.000708	CcSEcCtD
Carvedilol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	7.17e-05	0.000706	CcSEcCtD
Carvedilol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.1e-05	0.000699	CcSEcCtD
Carvedilol—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.1e-05	0.000699	CcSEcCtD
Carvedilol—Dizziness—Montelukast—chronic obstructive pulmonary disease	6.96e-05	0.000684	CcSEcCtD
Carvedilol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	6.94e-05	0.000683	CcSEcCtD
Carvedilol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000673	CcSEcCtD
Carvedilol—Vomiting—Formoterol—chronic obstructive pulmonary disease	6.83e-05	0.000672	CcSEcCtD
Carvedilol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	6.83e-05	0.000672	CcSEcCtD
Carvedilol—Rash—Arformoterol—chronic obstructive pulmonary disease	6.77e-05	0.000666	CcSEcCtD
Carvedilol—Rash—Formoterol—chronic obstructive pulmonary disease	6.77e-05	0.000666	CcSEcCtD
Carvedilol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	6.77e-05	0.000666	CcSEcCtD
Carvedilol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	6.77e-05	0.000666	CcSEcCtD
Carvedilol—Weight increased—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000665	CcSEcCtD
Carvedilol—Headache—Formoterol—chronic obstructive pulmonary disease	6.73e-05	0.000662	CcSEcCtD
Carvedilol—Headache—Arformoterol—chronic obstructive pulmonary disease	6.73e-05	0.000662	CcSEcCtD
Carvedilol—Weight decreased—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000662	CcSEcCtD
Carvedilol—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	6.72e-05	0.000661	CcSEcCtD
Carvedilol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	6.71e-05	0.00066	CcSEcCtD
Carvedilol—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.00066	CcSEcCtD
Carvedilol—Vomiting—Montelukast—chronic obstructive pulmonary disease	6.69e-05	0.000658	CcSEcCtD
Carvedilol—Rash—Montelukast—chronic obstructive pulmonary disease	6.63e-05	0.000653	CcSEcCtD
Carvedilol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	6.63e-05	0.000652	CcSEcCtD
Carvedilol—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	6.61e-05	0.000651	CcSEcCtD
Carvedilol—Depression—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.00065	CcSEcCtD
Carvedilol—Headache—Montelukast—chronic obstructive pulmonary disease	6.59e-05	0.000648	CcSEcCtD
Carvedilol—GJA1—Betamethasone—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.031	CbGdCrCtD
Carvedilol—GJA1—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.031	CbGdCrCtD
Carvedilol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000643	CcSEcCtD
Carvedilol—Angioedema—Prednisolone—chronic obstructive pulmonary disease	6.51e-05	0.000641	CcSEcCtD
Carvedilol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.000639	CcSEcCtD
Carvedilol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	6.45e-05	0.000634	CcSEcCtD
Carvedilol—Malaise—Prednisolone—chronic obstructive pulmonary disease	6.43e-05	0.000632	CcSEcCtD
Carvedilol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.00063	CcSEcCtD
Carvedilol—Rash—Salbutamol—chronic obstructive pulmonary disease	6.39e-05	0.000629	CcSEcCtD
Carvedilol—GJA1—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	6.39e-05	0.0302	CbGdCrCtD
Carvedilol—GJA1—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	6.39e-05	0.0302	CbGdCrCtD
Carvedilol—Syncope—Prednisolone—chronic obstructive pulmonary disease	6.39e-05	0.000629	CcSEcCtD
Carvedilol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	6.39e-05	0.000628	CcSEcCtD
Carvedilol—Nausea—Formoterol—chronic obstructive pulmonary disease	6.38e-05	0.000628	CcSEcCtD
Carvedilol—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.38e-05	0.000628	CcSEcCtD
Carvedilol—Headache—Salbutamol—chronic obstructive pulmonary disease	6.35e-05	0.000625	CcSEcCtD
Carvedilol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.26e-05	0.000616	CcSEcCtD
Carvedilol—Nausea—Montelukast—chronic obstructive pulmonary disease	6.25e-05	0.000615	CcSEcCtD
Carvedilol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.18e-05	0.000607	CcSEcCtD
Carvedilol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.15e-05	0.000605	CcSEcCtD
Carvedilol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.000596	CcSEcCtD
Carvedilol—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.02e-05	0.000593	CcSEcCtD
Carvedilol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	5.99e-05	0.00059	CcSEcCtD
Carvedilol—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000588	CcSEcCtD
Carvedilol—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000585	CcSEcCtD
Carvedilol—Oedema—Prednisolone—chronic obstructive pulmonary disease	5.82e-05	0.000572	CcSEcCtD
Carvedilol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	5.82e-05	0.000572	CcSEcCtD
Carvedilol—VEGFA—Betamethasone—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.0273	CbGdCrCtD
Carvedilol—VEGFA—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.0273	CbGdCrCtD
Carvedilol—Shock—Prednisolone—chronic obstructive pulmonary disease	5.72e-05	0.000563	CcSEcCtD
Carvedilol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	5.68e-05	0.000558	CcSEcCtD
Carvedilol—VEGFA—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	5.64e-05	0.0267	CbGdCrCtD
Carvedilol—VEGFA—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	5.64e-05	0.0267	CbGdCrCtD
Carvedilol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	5.62e-05	0.000553	CcSEcCtD
Carvedilol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000531	CcSEcCtD
Carvedilol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000529	CcSEcCtD
Carvedilol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.26e-05	0.000518	CcSEcCtD
Carvedilol—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.26e-05	0.000517	CcSEcCtD
Carvedilol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.22e-05	0.000514	CcSEcCtD
Carvedilol—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.00051	CcSEcCtD
Carvedilol—Pain—Prednisolone—chronic obstructive pulmonary disease	4.97e-05	0.000489	CcSEcCtD
Carvedilol—Vision blurred—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.00048	CcSEcCtD
Carvedilol—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000473	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	4.79e-05	0.000472	CcSEcCtD
Carvedilol—Anaemia—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000471	CcSEcCtD
Carvedilol—Angioedema—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000466	CcSEcCtD
Carvedilol—Malaise—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000459	CcSEcCtD
Carvedilol—Vertigo—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000458	CcSEcCtD
Carvedilol—Syncope—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000457	CcSEcCtD
Carvedilol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	4.62e-05	0.000455	CcSEcCtD
Carvedilol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.55e-05	0.000448	CcSEcCtD
Carvedilol—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000441	CcSEcCtD
Carvedilol—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.00044	CcSEcCtD
Carvedilol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000434	CcSEcCtD
Carvedilol—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000434	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000431	CcSEcCtD
Carvedilol—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.36e-05	0.000429	CcSEcCtD
Carvedilol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.29e-05	0.000422	CcSEcCtD
Carvedilol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000416	CcSEcCtD
Carvedilol—Oedema—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000416	CcSEcCtD
Carvedilol—Infection—Prednisone—chronic obstructive pulmonary disease	4.2e-05	0.000413	CcSEcCtD
Carvedilol—Shock—Prednisone—chronic obstructive pulmonary disease	4.16e-05	0.000409	CcSEcCtD
Carvedilol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000406	CcSEcCtD
Carvedilol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000404	CcSEcCtD
Carvedilol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.09e-05	0.000402	CcSEcCtD
Carvedilol—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.03e-05	0.000396	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.000379	CcSEcCtD
Carvedilol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	3.85e-05	0.000378	CcSEcCtD
Carvedilol—Insomnia—Prednisone—chronic obstructive pulmonary disease	3.82e-05	0.000376	CcSEcCtD
Carvedilol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	3.8e-05	0.000373	CcSEcCtD
Carvedilol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	3.72e-05	0.000366	CcSEcCtD
Carvedilol—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000361	CcSEcCtD
Carvedilol—Rash—Prednisolone—chronic obstructive pulmonary disease	3.67e-05	0.000361	CcSEcCtD
Carvedilol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.66e-05	0.00036	CcSEcCtD
Carvedilol—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000359	CcSEcCtD
Carvedilol—Headache—Prednisolone—chronic obstructive pulmonary disease	3.64e-05	0.000358	CcSEcCtD
Carvedilol—Constipation—Prednisone—chronic obstructive pulmonary disease	3.61e-05	0.000356	CcSEcCtD
Carvedilol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.48e-05	0.000343	CcSEcCtD
Carvedilol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.00034	CcSEcCtD
Carvedilol—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.46e-05	0.00034	CcSEcCtD
Carvedilol—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.36e-05	0.00033	CcSEcCtD
Carvedilol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.34e-05	0.000329	CcSEcCtD
Carvedilol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.34e-05	0.000329	CcSEcCtD
Carvedilol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.11e-05	0.000306	CcSEcCtD
Carvedilol—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.03e-05	0.000298	CcSEcCtD
Carvedilol—Pruritus—Prednisone—chronic obstructive pulmonary disease	2.99e-05	0.000294	CcSEcCtD
Carvedilol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	2.89e-05	0.000285	CcSEcCtD
Carvedilol—Dizziness—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000275	CcSEcCtD
Carvedilol—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.69e-05	0.000264	CcSEcCtD
Carvedilol—Rash—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000262	CcSEcCtD
Carvedilol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.66e-05	0.000262	CcSEcCtD
Carvedilol—Headache—Prednisone—chronic obstructive pulmonary disease	2.65e-05	0.000261	CcSEcCtD
Carvedilol—Nausea—Prednisone—chronic obstructive pulmonary disease	2.51e-05	0.000247	CcSEcCtD
Carvedilol—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.73e-06	6.01e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.72e-06	5.99e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.71e-06	5.97e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.7e-06	5.96e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.69e-06	5.95e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.68e-06	5.94e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.63e-06	5.87e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.62e-06	5.86e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.58e-06	5.81e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.54e-06	5.76e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.49e-06	5.7e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.46e-06	5.66e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.46e-06	5.66e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.45e-06	5.65e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.42e-06	5.61e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.41e-06	5.59e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.39e-06	5.57e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.35e-06	5.52e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.33e-06	5.5e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.32e-06	5.48e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.32e-06	5.48e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.3e-06	5.46e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.3e-06	5.45e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.29e-06	5.45e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.26e-06	5.41e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.24e-06	5.38e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.22e-06	5.36e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.22e-06	5.35e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.21e-06	5.34e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.19e-06	5.32e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	4.17e-06	5.29e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.16e-06	5.28e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.15e-06	5.27e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.13e-06	5.24e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.1e-06	5.21e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.1e-06	5.21e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.01e-06	5.09e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.98e-06	5.05e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.95e-06	5.01e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.94e-06	5e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.92e-06	4.98e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.92e-06	4.97e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.92e-06	4.97e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.91e-06	4.96e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.91e-06	4.96e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.91e-06	4.96e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.9e-06	4.95e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	3.9e-06	4.94e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.9e-06	4.94e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.88e-06	4.92e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.88e-06	4.92e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.87e-06	4.91e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.85e-06	4.89e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.84e-06	4.88e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.84e-06	4.87e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.83e-06	4.87e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.83e-06	4.86e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.82e-06	4.85e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.82e-06	4.85e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.77e-06	4.78e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.76e-06	4.78e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.74e-06	4.75e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.73e-06	4.73e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.73e-06	4.73e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.68e-06	4.67e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.64e-06	4.62e-05	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.64e-06	4.62e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.63e-06	4.6e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.62e-06	4.59e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.62e-06	4.59e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.6e-06	4.57e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.59e-06	4.55e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.57e-06	4.54e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.56e-06	4.52e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.55e-06	4.51e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.54e-06	4.5e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.54e-06	4.49e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.53e-06	4.48e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.51e-06	4.46e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.51e-06	4.45e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.5e-06	4.44e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.5e-06	4.44e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.48e-06	4.42e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.48e-06	4.42e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.47e-06	4.4e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.45e-06	4.38e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.43e-06	4.35e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.42e-06	4.34e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.33e-06	4.22e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.31e-06	4.21e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.31e-06	4.2e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.28e-06	4.16e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.26e-06	4.14e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.25e-06	4.13e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.24e-06	4.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.23e-06	4.11e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.22e-06	4.09e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.19e-06	4.05e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.19e-06	4.04e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.18e-06	4.04e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	3.16e-06	4.02e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.16e-06	4.02e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.16e-06	4.01e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.05e-06	3.88e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.05e-06	3.87e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-06	3.85e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	3.03e-06	3.84e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.01e-06	3.82e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.99e-06	3.79e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.96e-06	3.76e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.94e-06	3.73e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.92e-06	3.71e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.91e-06	3.7e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	3.68e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.9e-06	3.68e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.88e-06	3.65e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.88e-06	3.65e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.88e-06	3.65e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.86e-06	3.63e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.86e-06	3.63e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.85e-06	3.62e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.84e-06	3.6e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.83e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.83e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.81e-06	3.57e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.75e-06	3.48e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.72e-06	3.45e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.71e-06	3.44e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.69e-06	3.41e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.69e-06	3.41e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.67e-06	3.39e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.66e-06	3.38e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.65e-06	3.36e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.64e-06	3.36e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.63e-06	3.34e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.62e-06	3.33e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.62e-06	3.33e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.6e-06	3.3e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.56e-06	3.25e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.56e-06	3.25e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.55e-06	3.24e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.54e-06	3.23e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.53e-06	3.21e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.51e-06	3.18e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.5e-06	3.17e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.49e-06	3.16e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.47e-06	3.13e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	2.46e-06	3.13e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.43e-06	3.08e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.43e-06	3.08e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.4e-06	3.05e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.4e-06	3.04e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.39e-06	3.03e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.36e-06	3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.36e-06	2.99e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.34e-06	2.97e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.33e-06	2.95e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.33e-06	2.95e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.31e-06	2.93e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.31e-06	2.93e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.3e-06	2.92e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.3e-06	2.92e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.27e-06	2.89e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.27e-06	2.88e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	2.26e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.22e-06	2.82e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.21e-06	2.81e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.2e-06	2.79e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.2e-06	2.79e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.19e-06	2.78e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.16e-06	2.75e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.16e-06	2.75e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.16e-06	2.75e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.15e-06	2.73e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.13e-06	2.71e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.13e-06	2.7e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.12e-06	2.69e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.12e-06	2.69e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.11e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.1e-06	2.67e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.08e-06	2.64e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.07e-06	2.63e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.06e-06	2.62e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.06e-06	2.61e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.05e-06	2.6e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.04e-06	2.59e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.01e-06	2.56e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2e-06	2.54e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.97e-06	2.5e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.95e-06	2.47e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.92e-06	2.43e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.9e-06	2.41e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.89e-06	2.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.88e-06	2.39e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.87e-06	2.38e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.87e-06	2.37e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.85e-06	2.34e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.79e-06	2.27e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.77e-06	2.25e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.75e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.75e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.75e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.73e-06	2.2e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.72e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.72e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.7e-06	2.16e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.7e-06	2.16e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.7e-06	2.16e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.7e-06	2.15e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.68e-06	2.14e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.66e-06	2.11e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.66e-06	2.11e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.63e-06	2.07e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.63e-06	2.07e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-06	2.04e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.6e-06	2.04e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.59e-06	2.02e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.58e-06	2.01e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.58e-06	2e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.57e-06	2e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.57e-06	1.99e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.55e-06	1.96e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.54e-06	1.96e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-06	1.95e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.53e-06	1.94e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.52e-06	1.93e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.43e-06	1.82e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.43e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.42e-06	1.8e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.41e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.4e-06	1.78e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.4e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.38e-06	1.75e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.36e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.32e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.31e-06	1.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.3e-06	1.65e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.3e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.3e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.29e-06	1.64e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.28e-06	1.62e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.28e-06	1.62e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.21e-06	1.53e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.19e-06	1.51e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.15e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.07e-06	1.36e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.06e-06	1.34e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.05e-06	1.33e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1e-06	1.27e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.82e-07	1.25e-05	CbGpPWpGaD
